drugset / Trial / NCT02108158

A Safety and Efficacy Study of Different Injections Volumes of Botulinum Toxin Type A, Azzalure, in the Glabellar Lines

NCT02108158 ↗

Phase 4 Completed 62 enrolled Galderma R&D
RandomizedParallel-groupDouble-blindTreatment

Summary

A randomized, evaluator-blinded, comparative, study to evaluate the efficacy and safety of different injection volumes of botulinum toxin type A, Azzalure, in the glabellar lines.

Timeline

Start
2014-04
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Azzalure Protein / enzyme biologic 10 unknown —

Indications

No indication recorded.